Status:
UNKNOWN
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
Lead Sponsor:
University Hospital, Geneva
Conditions:
Breast Neoplasm
Eligibility:
FEMALE
19+ years
Brief Summary
The purpose of the study is: * to assess the potential benefits of 18F-\[FDG\] PET/CT and PET/MRI for operable breast cancer in order to define the size and location of the primary tumor, as well as ...
Detailed Description
Pre-operative FDG PET/CT, and in option PET/IRM, are intended for women with histologically confirmed operable clinically node-negative breast cancer, in whom breast conserving and post-operative radi...
Eligibility Criteria
Inclusion
- Histologically confirmed breast carcinoma
- Clinical stage T1-2 N0 M0
- Age \> 18 years
- Signed informed consent
Exclusion
- WHO performance index 3
- Premenopausal women without contraception
- Gestation
- Lactating
- Prior surgery or radiotherapy on the same breast
- Unable to understand study participation
- Bilateral breast cancer
- Prior CT thorax-abdomen and breast MRI within 4 months of interview
- Presence of electromechanical implant and/or body ferromagnetic material
- Previous history of renal insufficiency requiring dialysis and/or hospitalisation
- Ureum and/or creatinine within 2 weeks of interview above lab's reference limits
- History of contrast allergy
- Hyperthyroidy
- Claustrophobia.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01432002
Start Date
November 1 2007
End Date
December 1 2023
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radiation oncology, Geneva University Hospitals
Geneva, Switzerland, 1205